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Abstract
Objective: The objective of this study is to present the 3 months results of pterygium excision with adjunctive amniotic 
membrane graft.
Materials and Methods: In a non-comparative case series study, the medical records of all patients who had 
pterygium excision with adjunctive amniotic membrane transplant on bare sclera from December 2009 to August 2010 
were reviewed. All the patients were followed up for 3 months. The data collected were sex, age, occupation, type of 
pterygium (primary or recurrent), extent of pterygium, post-operative complications and recurrent pterygium growth.
Results: Thirty eyes of 30 consecutive patients were operated on. There were 14 males and 16 females (M:F =1:1); 
age range 25 to 70 years (mean: 48.3 SD + 12.01). Twenty-six eyes had primary and 4 recurrent pterygia. Stage 3 
pterygium accounted for most of the cases (53.3%) followed by stage 2 (36.7%) and stage 4 (10%). Nineteen patients 
(63.3%) had occupations with considerable exposure to actinic damage. Of these, manual laborers accounted for the 
highest number contributing 13 (43.3%) out of the 19 cases. Of the 30 patients 2 had a reoccurrence giving a recurrence 
rate of 6%. One patient developed dellen 1 week post-operatively with complete resolution following conservative large 
soft contact lens application.
Conclusion: Short term results suggests that adjunctive amniotic membrane transplant with pterygium excision is 
effective and safe. A larger randomized clinical trial with a longer follow-up period is however recommended.
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Introduction
A pterygium is a benign condition characterized by a 
wedge‑like fibrovascular growth of actinically damaged 
conjunctiva encroaching across the limbus and invading 
the cornea.[1]
It is a common surgical external eye problem presenting 
to the eye clinic. It affects all populations but principally 
prevalent in tropical Africa[2] as a result of its warm and dry 
climates. Several studies have reported prevalence of 8.8% 
in Ethiopia[2] and 9.5% in India.[3] In Nigeria, pterygium 
accounts for 9% of all new cases and 20% of all planned 
surgery in the eye clinic.[4]
The encroachment of the lesion onto the visual axis, 
its alteration of corneal contour inducing irregular 
astigmatism and breakup of precorneal tear film may result 
in diminution of vision requiring surgery. In a Nigerian 
study,[5] pterygium was responsible for 19% of visual 
impairment and 4% of blindness. However, treatment is 
usually complicated with high recurrence rate. This could 
be as high as 40% for the commonly practiced bare sclera 
technique.[4,6]
To prevent this post‑operative recurrence, two major 
adjunctive therapies are use of conjunctival or limbal 
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autograft or application of antimetabolites after the 
pterygium excision. The efficacy and safety of other proposed 
therapeutic modalities are yet to be extensively studied.
Lewallen,[6] and Bekibele[7] et al., reported a pterygium 
recurrence rate of 7% and 12.1% respectively with 
conjunctival autograft. Panda et al.,[8] Waziri‑Erameh et al.,[9] 
and Ma et al.,[10] in their series have reported recurrent rates of 
12%, 14% and 3.7% respectively with topical mitomycin‑C. In 
spite of the efficacy of this strategy the serious complications 
associated with the use of adjunctive antimetabolites with 
pterygium excision are well documented.[11,12] Waziri‑Erameh 
et al.,[9] reported conjunctival granuloma (12.8%), delayed 
healing (8.8%) and sclera melting (2.9%) as post‑operative 
complications. A local Indian study[13] reported a case each 
of scleromalacia and scleral calcification following use of 
adjunctive mitomycin C in pterygium surgery. Ajayi et al.,[14] 
studied the efficacy of post‑operative beta irradiation 
following pterygium surgery. Recurrence rate was found to 
be 6.9%. However, reported post‑operative complications 
included conjunctival inflammation (8.6%), corneal opacities 
(3.2%) and cataract (0.8%).
In recent times, preserved human amniotic membrane has 
been used for the treatment of many ocular surface disorders 
including chemical or thermal burns, Steven‑Johnson 
syndrome, ocular cicatricial pemphigoid, coverage of 
conjunctival defect after pterygium excision and deep 
corneal ulcers.[15,16]
Reports from several studies on the use of adjunctive 
amniotic membrane therapy for pterygium excision have 
shown different recurrence rates varying between 2%,[17] 
5.4%[10] to 40.9%[18] and 64%.[19]
The purpose of this study is to determine the short term 
outcome of pterygium excision with adjunctive amniotic 
membrane therapy in terms of recurrence of the lesion and 
complications.
Materials and Methods
In this retrospective case series, a review of medical records 
of all patients who had pterygium excision done between 
December 2009 and August 2010 was done at the Goutani 
Eye Institute, Rajahmundry, Andra Prandesh, India. Data 
on age, sex, occupation, type of pterygium (primary or 
recurrent), extent of pterygium, pterygium recurrence after 
3 months and post‑operative complications were analyzed. 
Ethical approval was received from Goutani Eye Institute, 
Rajahmundry, Andra Prandesh, India according to Helsinki 
declaration.
Preoperative evaluation
Visual acuity, slit lamp examination of the anterior segment 
and ocular adnexa, schirmer’s test, and tear film breakup 
time was performed on all the patients prior to surgery to 
rule out other ocular surface disorders.
The surgical procedure
All surgeries were done by one specific surgeon assisted by 
another specific surgeon using amniotic membrane tissue 
prepared by an eye bank and supplied in a preservative‑free 
liquid medium (glycerol) stored in a refrigerator. The surgery 
was done under local anesthesia in all the cases using 4cc of 
peribulbar 2% xylocaine and 0.5% bupivacaine (3:1) injection.
First the head of the pterygium was separated from the 
limbus and dissected toward s the center of the cornea 
using spring conjunctival scissors. The head and part of 
the body were then excised. Then the Tenon’s capsule and 
subconjunctival fibrovascular tissues were sparated from the 
overlying conjunctiva and excised upward and downward 
towards the medial caruncle being careful not to damage the 
medial rectus tendinous attachment. Bleeding vessels were 
gently cauterized. The conjunctiva was trimmed to create a 
bare sclera area of about 5 × 7 to 6 × 8 mm.
Residual fibrovascular tissue on the cornea was scraped with 
size 15 surgical blade.
Amniotic membrane transplantation: The bare sclera 
area was covered with amniotic membrane tissue with 
basement membrane side up. The amniotic membrane 
was sutured through the episcleral tissue to the adjacent 
healthy conjunctiva using 8 to 10 size 8.0 Vicryl sutures. 
All had 0.5 ml of 40 mg/ml non‑preserved subconjunctival 
injection of triamcinolone applied and the eye padded for 
24 h. Post‑operatively all patients were placed on eyedrops 
dexamethasone and ofloxacin 10 times per day for the first 
day, 8 times per day for the second day, 6 times per day for 
the third day, 4 times per day for the fourth day and 2 times 
per day for one month.
Follow‑up: Post‑operatively all patients were seen first day, 
1 week, 1 month, 2 months and then 3 months.
Study definition
For the purpose of this study, pterygium reoccurrence is 
the finding on slit lamp examination of formation of a 
wing of fibrovascular tissue occurring at the position of a 
previously excised pterygium with the apex crossing the 
limbus and extending onto the cornea, as distinct from 
‘simple vascularization of the corneal stroma’.
Data analysis
The data were analyzed using the Statistical Package for 
Social Sciences (SPSS‑16 IBM, Armonk, New York, USA). 
Univariate analysis and the parametric method were used 
to calculate frequency, percentage, and 95% confidence 
intervals (CI.), Chi‑square were done to ascertain the 
statistical significance of the results.
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Definitions for purposes of this study
Stage 1 pterygium: Apex of the pterygium is on the limbus
Stage 2 pterygium: The apex is between the limbus and 
pupillary margin
Stage 3 pterygium: The apex of the pterygium is on the 
pupillary margin
Stage 4: The apex of the pterygium is on the visual axis
Results
A total of 30 eyes of 30 patients were studied. There were 
14 males and 16 females (M:F  = 1:1) aged between 25 
and 70 years (mean: 48.3 SD + 12.01)
Twenty six (86.7%) had primary and 4 recurrent pterygia 
(13.3%), P  = 0.001, C.I (1.00‑1.26). The difference is 
statistically significant.
The sex and age distribution of the patients that had 
pterygium surgeries are presented in Table 1.
Stage 3 pterygium accounted for most of the cases (53.3%) 
followed by stage 2 (36.7%) and Stage 4 (10%) P = 0.014, 
C.I (2.49‑2.97).
Onset of growth ranged from 2 months to 10 years (mean 
2.62 SD + 2.56).
Nineteen patients (63.3%) had occupations with 
considerable exposure to actinic damage. Of these, manual 
laborers accounted for the highest number contributing to 
13 (43.3%) of 19 cases [Table 2].
Pterygium reoccurred in 2 eyes (6%) over the maximum 
follow‑up period of 3 months. The 2 recurrent cases were 
one each of primary and recurrent pterygia and one each 
of male and female.
One patient developed dellen 1 week post‑operatively with 
complete resolution following conservative management 
with large soft contact lens application. Otherwise, there 
was no significant change in the visual acuity and intraocular 
pressure of the patients post‑operatively.
Discussion
Different surgical treatments for pterygium have been 
advocated. However, recurrence remains a common 
complication.[20] The mechanism of pterygium recurrence 
has been attributed to surgical trauma, post‑operative 
inflammation, proliferation of fibroblasts and deposition of 
extracellular matrix protein.[21,22]
Recurrence rates as high as 40%[4,6] and 16.7%[23] have been 
observed in the bare sclera and primary closure techniques, 
respectively. To reduce this recurrence rate, adjunctive 
conjunctival autograft or topical mitomycin C could be 
used. Following pterygium excision with conjunctival 
autograft recurrence rates of 7%, 7.5% and 7.1% have 
been reported.[6,23,24] Topical mitomycin C has been as a 
method of reducing recurrence.[25,26] However, it has a 
recurrence rate of 38%[22] which is comparatively high. 
Moreover, some vision‑threatening side‑effects such as 
scleral ulceration, cataract formation and glaucoma have 
been reported.[11,12,27,28]
Being a natural basement membrane, the amniotic 
membrane contains various matrix proteins which promote 
the adherence, migration and differentiation of epithelial 
cells and prevent their apoptosis. It is thought that the 
major mechanisms by which amniotic membrane reduces 
recurrence of pterygium are promotion of conjunctival 
epithelial wound healing, suppression of fibroblasts and 
reduced extracellular matrix production.[10] This biomaterial 
may be considered as an alternative to conjunctival grafting 
in the treatment of pterygia.[17]
In this study, the mean age of the patients was 48.3 
SD±12.01. This is similar to those of other studies.[16,28] This 
may be a reflection of the active years when most people are 
involved in outdoor activities that exposes them to actinic 
degenerative changes on the conjunctiva.
Sixty‑two percent of the cohort were involved in 
occupation and lifestyle associated with considerable 
exposure to actinic damage to the conjunctiva. Of these, 
43% were manual laborers. Housewives accounted 
for 37% of patients with pterygium. It is possible that 
majority of these women are both housewives and also 
farmers largely involved in outdoor activities but due 
to socio‑cultural reasons prefer to indicate housewife 
as their primary occupation. In another study[23] 42% of 
the study population was involved in lifestyles associated 
Table 1: Age-sex distribution of patients that had 
pterygium surgery
Age group Frequency (sex) Total (%)
Male Female
21-40 5 4 9 (30)
41-60 7 9 16 (53.3)
>60 2 3 5 (16.7)
Total 14 16 30 (100)





Manual laborer 13 (43)
Driver 2 (7)
Total 30 (100)
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with environmental exposure with a risk of development 
of pterygium. This underscores the etiopathogenic 
importance of outdoor activities in the occurrence of 
pterygium.
In this study, a recurrence rate of 6% was recorded. This 
is lower than the findings in other studies which reported 
recurrence rates of 7.9%, 25% and 28.1%[23,29,30] respectively. 
Even though similar in that these cohorts comprised both 
primary and recurrent pterygia these studies differed in study 
design, sample size and follow‑up period. While this study 
evaluated 30 eyes with primary and recurrent pterygia who 
had pterygium excision with adjunctive amniotic membrane 
transplant, Kucukerdonmez et al.,[24] Katircioglu et al.,[29] 
and Luanratanakorn et al.,[30] studied 38, 16 and 287 eyes 
respectively. Kucukerdonmez et al.,[24] and Luanratanakorn 
et al.,[30] followed up their patients for 13.4 months (mean 
period) and 6 months respectively while follow‑up period 
of this study was just for 3 months. Again, while their 
studies were prospective this study was retrospective. In 
contrast, Nakamura et al.,[31] recorded no recurrence in 
their series. Their study however differed from this study in 
being prospective and had a longer mean follow‑up period 
of 13.9±6 months.
In the present study, only the minor post‑operative 
complication of dellen was reported. No significant 
sight‑threatening complications were recorded. These 
findings are similar those in other studies[16,31,32]
The low recurrence rate and no major post‑operative 
complication following amniotic membrane graft with 
pterygium excision in the present study agree with other 
reports that this procedure is effective and safe. However, 
due to the study’s major limitations which are it being 
retrospective, its small sample size and a short period of 
follow‑up, the findings should be interpreted with caution. 
A larger randomized controlled study will be required to 
confirm our findings.
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